Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for X4 Pharmaceuticals (XFOR) over the last 6 years, with Q3 2025 value amounting to 0.92%.

  • X4 Pharmaceuticals' Return on Invested Capital fell 7500.0% to 0.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92%, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of 0.36% for FY2024, which is 6500.0% up from last year.
  • Latest data reveals that X4 Pharmaceuticals reported Return on Invested Capital of 0.92% as of Q3 2025, which was down 7500.0% from 1.2% recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Return on Invested Capital ranged from a high of 0.09% in Q1 2025 and a low of 1.43% during Q1 2024
  • Moreover, its 5-year median value for Return on Invested Capital was 0.92% (2025), whereas its average is 0.8%.
  • Examining YoY changes over the last 5 years, X4 Pharmaceuticals' Return on Invested Capital showed a top increase of 13400bps in 2025 and a maximum decrease of -10400bps in 2025.
  • Over the past 5 years, X4 Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.86% in 2021, then decreased by -1bps to 0.87% in 2022, then fell by -8bps to 0.94% in 2023, then surged by 66bps to 0.32% in 2024, then crashed by -191bps to 0.92% in 2025.
  • Its Return on Invested Capital stands at 0.92% for Q3 2025, versus 1.2% for Q2 2025 and 0.09% for Q1 2025.